Navigation Links
Calibra Gains FDA Clearance to Market Finesse™ Insulin Patch-Pen for Three-Day Use With Novolog®
Date:7/26/2010

country.

Diabetes is a chronic, life-threatening disease caused by the body's failure to produce sufficient insulin or to utilize it correctly to control blood glucose levels. More than 98% of the 30 million people in the world who self-administer insulin use syringes and pens. However, many are challenged to overcome the difficulties and social stigma associated with delivering mealtime insulin multiple times every day with these devices. As a result, many fail to adhere to their dosing regimen, which can lead to adverse medical complications such as nerve damage, blindness, heart disease and kidney disease.

"Finesse will be easy for physicians and diabetes educators to explain to patients. Most patients want to eliminate the social embarrassment, elaborate preparation before each dose and the many daily needle sticks required by syringes and insulin pens," said Jeffrey L. Purvin, Calibra Medical's chairman and CEO. "Like expensive insulin pumps, Finesse provides fast, discreet, needle-free dosing. Yet, it accomplishes this with the simplicity, safety and affordability of syringes or insulin pens."

Finesse Delivers Insulin Quickly, Accurately, Affordably and Discreetly

Measuring roughly two inches long, one-inch wide and one-quarter inch thick, Finesse is a small, plastic device designed to be worn on the skin like a bandage. Patients fill the device with up to three days of insulin using a standard syringe. Finesse is operated discreetly through a user's clothing by squeezing together two buttons on the device. From start to finish, each dose takes seconds to complete. The device delivers insulin through a tiny, flexible plastic tube painlessly inserted into the skin after the device is filled. Finesse remains securely adhered to the body during typical daily activities such as showering, exercising
'/>"/>

SOURCE Calibra Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Profil Institute Teams Up With American Diabetes Association to Step Out Against Diabetes
2. DOAR Provides Trial Consulting Services in Victory for 5,600 Women in Gender Discrimination Class Action Trial Against Pharmaceutical Giant
3. Drug in New Class of Targeted Therapies Shows Early Promise Against Blood-Related Cancers
4. Assegai Wins Big Settlement Against ABBOTTs Subsidiary
5. Roche Announces Joint Initiative to Train Healthcare Workers in Africas Fight Against Cancer
6. Catalyst Pharmaceutical Partners Regains Compliance with NASDAQ Minimum Bid Price Rule
7. OnBase Gains Ground as Part of Healthcares Electronic Health Record
8. Whistleblower Kickback Case Against Alpharma Results In $42.5 Million Recovery for U.S. and States
9. Atherotech Recruits Top Experts in Fight Against Heart Disease
10. Adamas Pharmaceuticals TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models
11. Jury Verdict Against Novartis Pharmaceuticals For Retaliating Against Drug Sales Rep Who Took Maternity Leave
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ) has announced ... - Growth, Trends And Forecasts (2014 - 2019)" ... Asia Pacific market for Fluoroscopy is ... to 2020 Fluoroscopy is the imaging technology ... the interior of the body. The imaging team consists ...
(Date:5/27/2015)... May 27, 2015 ... du décalage horaire. Il nuit sérieusement à ... concentration durant les réunions de mi-journée et ... au mauvais moment dans votre chambre d,hôtel. ... décalage horaire risque de vous empêcher de ...
(Date:5/27/2015)... Donatelli, a senior marketing associate with the animal health division of Eli ... a healthcare setting in Bangkok, Thailand , will be ... need with respect and dignity is the guiding star for me and ... in a LillyPad blog . Donatelli and Lilly colleagues ... Colombia , France , Ukraine ...
Breaking Medicine Technology:Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 4Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3
... Decas SDCs Offer Greater Amounts of the Natural Compound Responsible ... Antioxidant and Anti-adhesion ... Inc.,announced today the results of new research showing that 1 ... has twice the,proanthocyanidin (PAC) level of an 8-ounce glass of ...
... MATEO, Calif., Dec. 12 BioForm Medical,Inc. (Nasdaq: ... a multi-center,randomized, blinded comparative study of nasolabial fold ... filler,than reported after treatment with either Juvederm(TM) or ... the December 2007 Filler Issue of,the Journal of ...
Cached Medicine Technology:Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6
(Date:5/27/2015)... Texas (PRWEB) May 27, 2015 ... the current state of the Omega-3 industry. The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ... Gc Rieber Oils, Camanchaca Fishing Company, Seadragon Marine ...
(Date:5/27/2015)... May 27, 2015 SonarMD, ... SonarMD Platform, a first-of-its kind, cloud-based algorithmic ... patients with chronic gastrointestinal disease. , Developed ... the application allows physicians to monitor their ... ongoing use of electronic health assessment surveys. ...
(Date:5/27/2015)... “Heroin has never been more plentiful or cheaper, ... from,” says Harford County Sheriff Jeff Gahler, as quoted by ... surging heroin related incidents in Baltimore, police resources are running ... heroin addiction and subsequent abuse before it turns into a ... is a drug and alcohol rehab facility specializing in heroin ...
(Date:5/27/2015)... Fernando Valley, CA (PRWEB) May 27, 2015 ... , Dr. Peyman Ghasri, is now offering discounts on facial ... every year after the age of 18. This lost collagen ... eyes, sunken cheeks, wrinkles and expression lines. Facial fillers are ... volume. Many people turn to facial fillers to create a ...
(Date:5/27/2015)... 27, 2015 A television program using ... and Roswell Park Cancer Institute winning ... award-winning story, Cancer Can’t Win , highlights the ... Cancer Institute. The production team followed five people who ... as they received treatment from doctors and medical experts ...
Breaking Medicine News(10 mins):Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3
... Southwestern Medical Center have determined that the level, or saturation, ... with sickle cell anemia who are at an increased risk ... also found that a published method used to predict severe ... Stroke is a serious but increasingly preventable complication of sickle ...
... cash flow from operations achieved for Q4 and the ... AMCS ),a leader in radiology and medical image ... the fourth,quarter and year ended December 31, 2007., ... Q4 Financial Highlights Revenue: Total revenues for ...
... Investigation into allergic reactions, deaths related to blood thinner ... Healthcare Corp., the pharmaceutical company at the center of ... that it was recalling any remaining multi-dose vials of ... company also said it was recalling its Hep-Lock heparin ...
... to Reliance on Spill-Proof,Cups, GLENDALE, Calif., Feb. 28 ... Dental Hygienists, Association,(CDHA) today urged parents and caregivers to ... "We all know that sippy cups are a godsend ... "But they need to be used wisely and,properly in ...
... The Board of Directors of,Belden (NYSE: BDC ... and member of,the Compensation Committee of the board. Ms. ... Resources at Pfizer Inc., a post she has held,since ... world,s largest global,research-based pharmaceutical company. Prior to joining Pfizer, ...
... Changes in standards support Department of Health ... improvement, WASHINGTON, Feb. 28 Today ... its Core Accreditation standards. The Core,standards are ... functions within health care organization such as ...
Cached Medicine News:Health News:UT Southwestern researchers investigate predictors for sickle-cell-anemia complications 2Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 2Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 3Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 4Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 5Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 6Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 7Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 8Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 9Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 10Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 11Health News:Baxter Recalls Rest of Heparin Products 2Health News:Baxter Recalls Rest of Heparin Products 3Health News:California Dental Hygienists Offer Tips for Safe Sippy Cup Use 2Health News:Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors 2Health News:URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards 2Health News:URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards 3
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
Red Rubber Robinson Catheters (Latex)...
Silver Foley Catheter 3-way...
Silicone-Coated Foley Catheter 2-Way...
Medicine Products: